Mount Sinai treats first prostate cancer patient with Profound's TULSA-PRO system

Profound Medical Corp.

Mount Sinai Hospital (ranked #6 for Urology) is first in Metro New York to offer TULSA-PRO incision-free, MRI-guided prostate treatment.
Procedure uses AI-powered, directional ultrasound from inside urethra to heat tissue to 55-57°C while protecting nerves; no blood loss or overnight stay.
Patient discharged same day; initial treatment outcome positive.
Profound CEO Arun Menawat noted collaboration between Urology and Interventional Radiology at Mount Sinai.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.